Metabolic Characterization of Vamorolone in Human Liver Microsomes: Implications for Anti‐Doping

Documenti analoghi

• Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing
  di: Zhongquan Li, et al.
  Pubblicazione: (2025)
• New Metabolites of Methyldienolone by In Vitro Human Liver Microsomes and Characterized Using LC/HRMS for Doping Control Purposes
  di: Jinghua Hou, et al.
  Pubblicazione: (2025)
• Metabolism of Six Novel Nitazenes in Human Liver Microsomes Based on Ultra‐High‐Performance Liquid Chromatography Coupled With High‐Resolution Mass Spectrometry
  di: Bo‐yu Huang, et al.
  Pubblicazione: (2024)
• The Evolution of Precision Anti‐Doping From UGT2B17 Polymorphism Insights to Integrated Detection Frameworks
  di: Jiahui Cheng, et al.
  Pubblicazione: (2026)
• Phase I Metabolism of Novel Phencyclidine Derivative 3‐Cl‐PCP: In Vitro Studies With Pooled Human Liver Microsomes and Investigation of a Post‐Mortem Case
  di: Johannes Kutzler, et al.
  Pubblicazione: (2026)